RU2017101102A - Способы лечения зуда - Google Patents
Способы лечения зуда Download PDFInfo
- Publication number
- RU2017101102A RU2017101102A RU2017101102A RU2017101102A RU2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A
- Authority
- RU
- Russia
- Prior art keywords
- paragraphs
- subject
- antipruritic agent
- dose
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462011936P | 2014-06-13 | 2014-06-13 | |
| US62/011,936 | 2014-06-13 | ||
| PCT/US2015/035650 WO2015192071A1 (en) | 2014-06-13 | 2015-06-12 | Methods for treating pruritus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2017101102A true RU2017101102A (ru) | 2018-07-16 |
| RU2017101102A3 RU2017101102A3 (cg-RX-API-DMAC7.html) | 2019-01-28 |
Family
ID=54834447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017101102A RU2017101102A (ru) | 2014-06-13 | 2015-06-12 | Способы лечения зуда |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20150359789A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3154546A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017517553A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20170016983A (cg-RX-API-DMAC7.html) |
| CN (1) | CN106535897A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015274327A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016029236A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2951420A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL249475A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016016404A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2017101102A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015192071A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| WO2017120468A1 (en) * | 2016-01-06 | 2017-07-13 | Trevi Therapeutics, Inc. | Therapeutic use of nalbuphine without aquaretic effects |
| MX382608B (es) * | 2016-03-21 | 2025-03-13 | Trevi Therapeutics Inc | Tratamiento del prurito urémico. |
| JP2019532112A (ja) * | 2016-10-25 | 2019-11-07 | トレビ セラピューティクス インコーポレイテッド | 結節性痒疹の治療方法 |
| MX2020009813A (es) * | 2018-03-29 | 2020-11-11 | Lumosa Therapeutics Co Ltd | Composiciones y metodos para tratar el prurito. |
| CA3105680A1 (en) * | 2018-07-11 | 2020-01-16 | Trevi Therapeutics, Inc. | Treatment of the pruritic symptoms of liver disease |
| AU2019309913B2 (en) * | 2018-07-23 | 2025-02-27 | Trevi Therapeutics, Inc. | Treatment of chronic cough, breathlessness and dyspnea |
| AU2021206252A1 (en) | 2020-01-10 | 2022-07-28 | Trevi Therapeutics, Inc. | Methods of administering nalbuphine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8394812B2 (en) * | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
| EP1931315B1 (en) * | 2005-08-24 | 2013-10-16 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
| EP2150247B1 (en) * | 2007-04-23 | 2012-10-31 | Symrise AG | Polyethylene glycol esters and cosmetic and/or dermatological preparations |
| US8987289B2 (en) * | 2012-12-14 | 2015-03-24 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| US8637538B1 (en) * | 2012-12-14 | 2014-01-28 | Trevi Therapeutics, Inc. | Methods for treatment of pruritis |
| US20140179727A1 (en) * | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| NZ708371A (en) * | 2012-12-14 | 2020-05-29 | Trevi Therapeutics Inc | Methods for treating pruritus |
-
2015
- 2015-06-12 RU RU2017101102A patent/RU2017101102A/ru not_active Application Discontinuation
- 2015-06-12 JP JP2016572657A patent/JP2017517553A/ja active Pending
- 2015-06-12 BR BR112016029236A patent/BR112016029236A2/pt not_active Application Discontinuation
- 2015-06-12 MX MX2016016404A patent/MX2016016404A/es unknown
- 2015-06-12 CN CN201580039250.9A patent/CN106535897A/zh active Pending
- 2015-06-12 WO PCT/US2015/035650 patent/WO2015192071A1/en not_active Ceased
- 2015-06-12 EP EP15807379.1A patent/EP3154546A4/en not_active Withdrawn
- 2015-06-12 AU AU2015274327A patent/AU2015274327A1/en not_active Abandoned
- 2015-06-12 KR KR1020177001115A patent/KR20170016983A/ko not_active Withdrawn
- 2015-06-12 CA CA2951420A patent/CA2951420A1/en not_active Abandoned
- 2015-06-12 US US14/738,550 patent/US20150359789A1/en not_active Abandoned
-
2016
- 2016-12-11 IL IL249475A patent/IL249475A0/en unknown
-
2018
- 2018-04-30 US US15/966,850 patent/US20190099416A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017101102A3 (cg-RX-API-DMAC7.html) | 2019-01-28 |
| CN106535897A (zh) | 2017-03-22 |
| US20150359789A1 (en) | 2015-12-17 |
| EP3154546A4 (en) | 2018-01-10 |
| MX2016016404A (es) | 2017-11-30 |
| BR112016029236A2 (pt) | 2017-11-07 |
| CA2951420A1 (en) | 2015-12-17 |
| EP3154546A1 (en) | 2017-04-19 |
| US20190099416A1 (en) | 2019-04-04 |
| KR20170016983A (ko) | 2017-02-14 |
| IL249475A0 (en) | 2017-02-28 |
| WO2015192071A1 (en) | 2015-12-17 |
| AU2015274327A1 (en) | 2017-01-05 |
| JP2017517553A (ja) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017101102A (ru) | Способы лечения зуда | |
| RU2015128265A (ru) | Способы лечения зуда | |
| JP2016506398A5 (cg-RX-API-DMAC7.html) | ||
| JP2017517553A5 (cg-RX-API-DMAC7.html) | ||
| EP3390367B1 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| DD244293A5 (de) | Verfahren zur herstellung eines arzneimittels | |
| JP2019131588A5 (ja) | 抗そう痒剤 | |
| AU2017327383A1 (en) | Method of reducing thyroid-associated side effects | |
| FI3463345T3 (fi) | Farmaseuttisia yhdistelmiä | |
| JP2022525202A (ja) | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 | |
| JP2018521047A (ja) | 掻痒の治療 | |
| JP2015519398A5 (cg-RX-API-DMAC7.html) | ||
| JP2019509309A5 (cg-RX-API-DMAC7.html) | ||
| JP2017527627A (ja) | 喫煙者における非小細胞肺癌の治療のための、カルボプラチンおよびパクリタキセルと併用したベリパリブ | |
| WO2010110428A1 (ja) | 掻痒の予防及び／または治療剤 | |
| JP2020514347A (ja) | チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤 | |
| MX2007012052A (es) | Composiciones y sales dermatologicas para el tratamiento de enfermedades dermatologicas. | |
| RU2388474C2 (ru) | Применение производного дигидроимидазопиразина для лечения или предупреждения боли | |
| WO2021091846A1 (en) | Treatment of mast cell diseases and eosinophilic disorders | |
| CN112402420A (zh) | 钩吻素子在制备用于治疗炎症性肠病的药物中的用途 | |
| US20240122956A1 (en) | Application of Naringin Combined with Rapamycin in Preparation of Medications for Treating Hyperlipidemia | |
| CN108969523A (zh) | 化合物在制备治疗转移性癌症的药物中的应用 | |
| RU2024111332A (ru) | Ресметиром для уменьшения объема печени | |
| US9284281B2 (en) | Indication of naphtho[2,3-F]quinoxaline-7,12-dione compound in alleviating pain | |
| HK40041872A (en) | Method for preventing and/or treating aging-associated cognitive impairment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20190520 |